These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23810915)

  • 21. Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer.
    Cox DG; Pontes C; Guino E; Navarro M; Osorio A; Canzian F; Moreno V;
    Br J Cancer; 2004 Jul; 91(2):339-43. PubMed ID: 15173859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Glycosylated PTGS2 in Colorectal Cancer for NSAIDS-Based Adjuvant Therapy.
    Venè R; Costa D; Augugliaro R; Carlone S; Scabini S; Casoni Pattacini G; Boggio M; Zupo S; Grillo F; Mastracci L; Pitto F; Minghelli S; Ferrari N; Tosetti F; Romairone E; Mingari MC; Poggi A; Benelli R
    Cells; 2020 Mar; 9(3):. PubMed ID: 32168749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial.
    Hamy AS; Tury S; Wang X; Gao J; Pierga JY; Giacchetti S; Brain E; Pistilli B; Marty M; Espié M; Benchimol G; Laas E; Laé M; Asselain B; Aouchiche B; Edelman M; Reyal F
    J Clin Oncol; 2019 Mar; 37(8):624-635. PubMed ID: 30702971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of c-Met in colorectal cancer: a meta-analysis.
    Liu Y; Yu XF; Zou J; Luo ZH
    World J Gastroenterol; 2015 Mar; 21(12):3706-10. PubMed ID: 25834339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphovascular invasion is a high risk factor for stage I/II colorectal cancer: a systematic review and meta-analysis.
    Yuan H; Dong Q; Zheng B; Hu X; Xu JB; Tu S
    Oncotarget; 2017 Jul; 8(28):46565-46579. PubMed ID: 28430621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
    Wu SW; Ma CC; Li WH
    Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTGS2 (COX2) -765G>C gene polymorphism and risk of sporadic colorectal cancer in Iranian population.
    Daraei A; Salehi R; Mohamadhashem F
    Mol Biol Rep; 2012 May; 39(5):5219-24. PubMed ID: 22173719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: a meta-analysis of observational studies.
    Lee JY; Myung SK; Song YS
    Gynecol Oncol; 2013 Jun; 129(3):613-9. PubMed ID: 23422504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses' health study and health professionals follow-up study.
    Momen-Heravi F; Masugi Y; Qian ZR; Nishihara R; Liu L; Smith-Warner SA; Keum N; Zhang L; Tchrakian N; Nowak JA; Yang W; Ma Y; Bowden M; da Silva A; Wang M; Fuchs CS; Meyerhardt JA; Ng K; Wu K; Giovannucci E; Ogino S; Zhang X
    Int J Cancer; 2017 Dec; 141(12):2471-2479. PubMed ID: 28856682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
    Fellhofer-Hofer J; Franz C; Vey JA; Kahlert C; Kalkum E; Mehrabi A; Halama N; Probst P; Klupp F
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of COX-2 immunohistochemical expression evaluated by quantitative image analysis in colorectal cancer.
    Zafirellis K; Agrogiannis G; Zachaki A
    APMIS; 2008 Oct; 116(10):912-22. PubMed ID: 19132985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
    Hamada T; Cao Y; Qian ZR; Masugi Y; Nowak JA; Yang J; Song M; Mima K; Kosumi K; Liu L; Shi Y; da Silva A; Gu M; Li W; Keum N; Zhang X; Wu K; Meyerhardt JA; Giovannucci EL; Giannakis M; Rodig SJ; Freeman GJ; Nevo D; Wang M; Chan AT; Fuchs CS; Nishihara R; Ogino S
    J Clin Oncol; 2017 Jun; 35(16):1836-1844. PubMed ID: 28406723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term prognostic value of preoperative anemia in patients with colorectal cancer: A systematic review and meta-analysis.
    Wilson MJ; van Haaren M; Harlaar JJ; Park HC; Bonjer HJ; Jeekel J; Zwaginga JJ; Schipperus M
    Surg Oncol; 2017 Mar; 26(1):96-104. PubMed ID: 28317592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.
    Hubner RA; Muir KR; Liu JF; Logan RFA; Grainge MJ; Houlston RS;
    Int J Cancer; 2007 Nov; 121(9):2001-2004. PubMed ID: 17640058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.
    Huang Q; Li S; Cheng P; Deng M; He X; Wang Z; Yang CH; Zhao XY; Huang J
    World J Gastroenterol; 2017 Jul; 23(27):5018-5033. PubMed ID: 28785155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A meta-analysis of PTGS1 and PTGS2 polymorphisms and NSAID intake on the risk of developing cancer.
    Nagao M; Sato Y; Yamauchi A
    PLoS One; 2013; 8(8):e71126. PubMed ID: 23967159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis.
    Xing X; Cai W; Shi H; Wang Y; Li M; Jiao J; Chen M
    Br J Cancer; 2013 Jun; 108(12):2542-8. PubMed ID: 23703248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes mellitus and colorectal cancer prognosis: a meta-analysis.
    Mills KT; Bellows CF; Hoffman AE; Kelly TN; Gagliardi G
    Dis Colon Rectum; 2013 Nov; 56(11):1304-19. PubMed ID: 24105007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin use and survival after diagnosis of colorectal cancer.
    Chan AT; Ogino S; Fuchs CS
    JAMA; 2009 Aug; 302(6):649-58. PubMed ID: 19671906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of Ki-67 is a poor prognostic marker for colorectal cancer patients: a meta analysis.
    Luo ZW; Zhu MG; Zhang ZQ; Ye FJ; Huang WH; Luo XZ
    BMC Cancer; 2019 Feb; 19(1):123. PubMed ID: 30727976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.